|
1
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lalle M, De Rosa L, Marzetti L and
Montuoro A: Detection of breast cancer cells in the bone marrow or
peripheral blood: Methods and prognostic significance. Tumori.
86:183–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Van Der Pluijm G, Sijmons B, Vloedgraven
H, Deckers M, Papapoulos S and Löwik C: Monitoring metastatic
behavior of human tumor cells in mice with species-specific
polymerase chain reaction: Elevated expression of angiogenesis and
bone resorption stimulators by breast cancer in bone metastases. J
Bone Miner Res. 16:1077–1091. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Van Driel M and Van Leeuwen JP: Cancer and
bone: A complex complex. Arch Biochem Biophys. 561:159–166. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynch ME and Fischbach C: Biomechanical
forces in the skeleton and their relevance to bone metastasis:
Biology and engineering considerations. Adv Drug Deliv Rev.
79-80:119–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Biol. 17:816–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sceneay J, Parker BS, Smyth MJ and Möller
A: Hypoxia-driven immunosuppression contributes to the
pre-metastatic niche. Oncoimmunology. 2:e223552013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sceneay J, Smyth MJ and Möller A: The
pre-metastatic niche: Finding common ground. Cancer Metastasis Rev.
32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo
J, Li HM, Zhang WS, Chen CY and Xie H: Exosomes from human
umbilical cord blood accelerate cutaneous wound healing through
miR-21-3p-mediated promotion of angiogenesis and fibroblast
function. Theranostics. 8:169–184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CY, Rao SS, Ren L, Hu XK, Tan YJ, Hu
Y, Luo J, Liu YW, Yin H, Huang J, et al: Exosomal DMBT1 from human
urine-derived stem cells facilitates diabetic wound repair by
promoting angiogenesis. Theranostics. 8:1607–1623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Record M, Silvente-Poirot S, Poirot M and
Wakelam MJO: Extracellular vesicles: Lipids as key components of
their biogenesis and functions. J Lipid Res. 59:1316–1324. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun Y and Liu J: Potential of cancer cell
derived exosomes in clinical application: A review of recent
research advances. Clin Ther. 36:863–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yáñezmó M, Siljander PR, Andreu Z, Zavec
AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J,
et al: Biological properties of extracellular vesicles and their
physiological functions. J Extracell Vesicles. 4:270662015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeelenberg IS, Ostrowski M, Krumeich S,
Bobrie A, Jancic C, Boissonnas A, Delcayre A, Le Pecq JB,
Combadière B, Amigorena S and Théry C: Targeting tumor antigens to
secreted membrane vesicles in vivo induces efficient antitumor
immune responses. Cancer Res. 68:1228–1235. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kumar S and Reddy PH: Are circulating
microRNAs peripheral biomarkers for Alzheimer's disease? Biochim
Biophys Acta. 1862:1617–1627. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li JJ, Wang B, Kodali MC, Chao C, Kim E,
Patters BJ, Lan L, Kumar S, Wang X, Yue J and Liao FF: In vivo
evidence for the contribution of peripheral circulating
inflammatory exosomes to neuroinflammation. J Neuroinflammation.
15:82018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lässer C, Alikhani VS, Ekström K, Eldh M,
Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S, Lötvall J and
Valadi H: Human saliva, plasma and breast milk exosomes contain
RNA: Uptake by macrophages. J Transl Med. 9:92011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Admyre C, Johansson SM, Qazi KR, Filén JJ,
Lahesmaa R, Norman M, Neve EP, Scheynius A and Gabrielsson S:
Exosomes with immune modulatory features are present in human
breast milk. J Immunol. 179:1969–1978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Street JM, Barran PE, Mackay CL, Weidt S,
Balmforth C, Walsh TS, Chalmers RT, Webb DJ and Dear JW:
Identification and proteomic profiling of exosomes in human
cerebrospinal fluid. J Transl Med. 10:52012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vojtech L, Woo S, Hughes S, Levy C,
Ballweber L, Sauteraud RP, Strobl J, Westerberg K, Gottardo R,
Tewari M and Hladik F: Exosomes in human semen carry a distinctive
repertoire of small non-coding RNAs with potential regulatory
functions. Nucleic Acids Res. 42:7290–7304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hong BS, Cho JH, Kim H, Choi EJ, Rho S,
Kim J, Kim JH, Choi DS, Kim YK, Hwang D and Gho YS: Colorectal
cancer cell-derived microvesicles are enriched in cell
cycle-related mRNAs that promote proliferation of endothelial
cells. BMC Genomics. 10:5562009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumar B, Garcia M, Murakami JL and Chen
CC: Exosome-mediated microenvironment dysregulation in leukemia.
Biochim Biophys Acta. 1863:464–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Suetsugu A, Honma K, Saji S, Moriwaki H,
Ochiya T and Hoffman RM: Imaging exosome transfer from breast
cancer cells to stroma at metastatic sites in orthotopic nude-mouse
models. Adv Drug Deliv Rev. 65:383–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kogure T, Lin WL, Yan IK, Braconi C and
Patel T: Intercellular nanovesicle-mediated microRNA transfer: A
mechanism of environmental modulation of hepatocellular cancer cell
growth. Hepatology. 54:1237–1248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu S, Cao H, Shen B and Feng J:
Tumor-derived exosomes in cancer progression and treatment failure.
Oncotarget. 6:37151–37168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luga V and Wrana JL: Tumor-stroma
interaction: Revealing fibroblast-secreted exosomes as potent
regulators of Wnt-planar cell polarity signaling in cancer
metastasis. Cancer Res. 73:6843–6847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shao Y, Shen Y, Chen T, Xu F, Chen X and
Zheng S: The functions and clinical applications of tumor-derived
exosomes. Oncotarget. 7:60736–60751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Corrado C, Raimondo S, Chiesi A, Ciccia F,
De Leo G and Alessandro R: Exosomes as intercellular signaling
organelles involved in health and disease: Basic science and
clinical applications. Int J Mol Sci. 14:5338–5366. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kowal J, Tkach M and Théry C: Biogenesis
and secretion of exosomes. Curr Opin Cell Biol. 29:116–125. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ekström EJ, Bergenfelz C, von Bülow V,
Serifler F, Carlemalm E, Jönsson G, Andersson T and Leandersson K:
WNT5A induces release of exosomes containing pro-angiogenic and
immunosuppressive factors from malignant melanoma cells. Mol
Cancer. 13:882014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Man YG, Stojadinovic A, Mason J, Avital I,
Bilchik A, Bruecher B, Protic M, Nissan A, Izadjoo M, Zhang X and
Jewett A: Tumor-infiltrating immune cells promoting tumor invasion
and metastasis: Existing theories. J Cancer. 4:84–95. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xue M, Zhuo Y and Shan B: MicroRNAs, long
noncoding RNAs, and their functions in human disease. Methods Mol
Biol. 1617:1–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thomou T, Mori MA, Dreyfuss JM, Konishi M,
Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R,
Grinspoon SK, et al: Adipose-derived circulating miRNAs regulate
gene expression in other tissues. Nature. 542:450–455. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luga V, Zhang L, Viloria-Petit AM,
Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and
Wrana JL: Exosomes mediate stromal mobilization of autocrine
Wnt-PCP signaling in breast cancer cell migration. Cell.
151:1542–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
van Balkom BW, de Jong OG, Smits M,
Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel
DM, Stoorvogel W, Würdinger T and Verhaar MC: Endothelial
cellsrequire miR-214 to secrete exosomes that suppress senescence
and induce angiogenesis in human and mouse endothelial cells.
Blood. 121:3997–4006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cui Y, Luan J, Li H, Zhou X and Han J:
Exosomes derived from mineralizing osteoblasts promote ST2 cell
osteogenic differentiation by alteration of microRNA expression.
FEBS Lett. 590:185–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Henderson MC and Azorsa DO: The genomic
and proteomic content of cancer cellderived exosomes. Front Oncol.
2:382012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nolte-'t Hoen EN, Buermans HP, Waasdorp M,
Stoorvogel W, Wauben MH and 't Hoen PA: Deep sequencing of RNA from
immune cell-derived vesicles uncovers the selective incorporation
of small non-coding RNA biotypes with potential regulatory
functions. Nucleic Acids Res. 40:9272–9285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cazzoli R, Buttitta F, Di Nicola M,
Malatesta S, Marchetti A, Rom WN and Pass HI: microRNAs derived
from circulating exosomes as noninvasive biomarkers for screening
and diagnosing lung cancer. J Thorac Oncol. 8:1156–1162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Corcoran C, Friel AM, Duffy MJ, Crown J
and O'Driscoll L: Intracellular and extracellular microRNAs in
breast cancer. Clin Chem. 57:18–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889 Cancer Metastasis Rev.
8:98–101. 1889.
|
|
48
|
Brennan MF and Ekman L: Metabolic
consequences of nutritional support of the cancer patient. Cancer.
54 (11 Suppl):S2627–S2634. 1984. View Article : Google Scholar
|
|
49
|
Guise TA, Mohammad KS, Clines G, Stebbins
EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L
and Chirgwin JM: Basic mechanisms responsible for osteolytic and
osteoblastic bone metastases. Clin Cancer Res. 12:6213s–6216s.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kingsley LA, Fournier PG, Chirgwin JM and
Guise TA: Molecular biology of bone metastasis. Mol Cancer Ther.
6:2609–2617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pantel K, Müller V, Auer M, Nusser N,
Harbeck N and Braun S: Detection and clinical implications of early
systemic tumor cell dissemination in breast cancer. Clin Cancer
Res. 9:6326–6334. 2003.PubMed/NCBI
|
|
52
|
Aft R, Naughton M, Trinkaus K, Watson M,
Ylagan L, Chavez-Macgregor M, Zhai J, Kuo S, Shannon W, Diemer K,
et al: Effect of zoledronic acid on disseminated tumour cells in
women with locally advanced breast cancer: An open label,
randomised, phase 2 trial. Lancet Oncol. 11:421–428. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen H, Senda T and Kubo KY: The osteocyte
plays multiple roles in bone remodeling and mineral homeostasis.
Med Mol Morphol. 48:61–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Saleem SN and Abdel-Mageed AB:
Tumor-derived exosomes in oncogenic reprogramming and cancer
progression. Cell Mol Life Sci. 72:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Clézardin P: The role of
RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone
diseases: Physiopathology and clinical implications. Bull Cancer.
98:837–846. 2011.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sanders JL, Chattopadhyay N, Kifor O,
Yamaguchi T, Butters RR and Brown EM: Extracellular calcium-sensing
receptor expression and its potential role in regulating
parathyroid hormone-related peptide secretion in human breast
cancer cell lines. Endocrinology. 141:4357–4364. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Siveen KS, Prabhu K, Krishnankutty R,
Kuttikrishnan S, Tsakou M, Alali FQ, Dermime S, Mohammad RM and
Uddin S: Vascular endothelial growth factor (VEGF) signaling in
tumour vascularization: Potential and challenges. Curr Vasc
Pharmacol. 15:339–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Heldin CH, Lennartsson J and Westermark B:
Involvement of platelet-derived growth factor ligands and receptors
in tumorigenesis. J Intern Med. 283:16–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chirgwin JM, Mohammad KS and Guise TA:
Tumor-bone cellular interactions in skeletal metastases. J
Musculoskeletal Neuronal Interact. 4:308–318. 2004.
|
|
61
|
Chang AC, Chen PC, Lin YF, Su CM, Liu JF,
Lin TH, Chuang SM and Tang CH: Osteoblast-secreted WISP-1 promotes
adherence of prostate cancer cells to bone via the VCAM-1/integrin
α4β1 system. Cancer Lett. 426:47–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
D'Oronzo S, Brown J and Coleman R: The
role of biomarkers in the management of bone-homing malignancies. J
Bone Oncol. 9:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Berruti A, Libè R, Laganà M, Ettaieb H,
Sukkari MA, Bertherat J, Feelders RA, Grisanti S, Cartry J,
Mazziotti G, et al: Morbidity and mortality of bone metastases in
advanced adrenocortical carcinoma: A multicenter retrospective
study. Eur J Endocrinol. 180:311–320. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q,
Wang L, Hao YQ, Chen DC, Tang H, Peng YD, et al: Clinical
characteristics associated with bone mineral density improvement
after 1-year alendronate/vitamin d3 or calcitriol treatment:
Exploratory results from a phase 3, randomized, controlled trial on
postmenopausal osteoporotic women in China. Medicine (Baltimore).
97:e116942018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Stopeck AT, Lipton A, Body JJ, Steger GG,
Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA,
Viniegra M, et al: Denosumab compared with zoledronic acid for the
treatment of bone metastases in patients with advanced breast
cancer: A randomized, double-blind study. J Clin Oncol.
28:5132–5139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Body JJ, Lipton A, Gralow J, Steger GG,
Gao G, Yeh H and Fizazi K: Effects of denosumab in patients with
bone metastases with and without previous bisphosphonate exposure.
J Bone Miner Res. 25:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Fizazi K, Lipton A, Mariette X, Body JJ,
Rahim Y, Gralow JR, Gao G, Wu L, Sohn W and Jun S: Randomized phase
II trial of denosumab in patients with bone metastases from
prostate cancer, breast cancer, or other neoplasms after
intravenous bisphosphonates. J Clin Oncol. 27:1564–1571. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hirbe A, Morgan EA, Uluçkan O and
Weilbaecher K: Skeletal complications of breast cancer therapies.
Clin Cancer Res. 12:6309s–6314s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Fizazi K, Carducci M, Smith M, Damião R,
Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, et al:
Denosumab versus zoledronic acid for treatment of bone metastases
in men with castration-resistant prostate cancer: A randomised,
double-blind study. Lancet. 377:813–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J,
Zhou K, Liu X, Ren X, Wang F, et al: Cancer-derived exosomal
miR-25-3p promotes pre-metastatic niche formation by inducing
vascular permeability and angiogenesis. Nat Commun. 9:53952018.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sethi N and Kang Y: Unravelling the
complexity of metastasis-molecular understanding and targeted
therapies. Nat Rev Cancer. 11:735–748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Psaila B and Lyden D: The metastatic
niche: Adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
O'Brien K, Rani S, Corcoran C, Wallace R,
Hughes L, Friel AM, McDonnell S, Crown J, Radomski MW and
O'Driscoll L: Exosomes from triple-negative breast cancer cells can
transfer phenotypic traits representing their cells of origin to
secondary cells. Eur J Cancer. 49:1845–1859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med (Berl). 91:431–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Logozzi M, De Milito A, Lugini L, Borghi
M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi
E, et al: High levels of exosomes expressing CD63 and caveolin-1 in
plasma of melanoma patients. PLoS One. 4:e52192009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Tavoosidana G, Ronquist G, Darmanis S, Yan
J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, et al:
Multiple recognition assay reveals prostasomes as promising plasma
biomarkers for prostate cancer. Proc Natl Acad Sci USA.
108:8809–8814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Steinbichler TB, Dudás J, Riechelmann H
and Skvortsovab II: The role of exosomes in cancer metastasis.
Semin Cancer Biol. 44:170–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Gao D, Nolan D, McDonnell K, Vahdat L,
Benezra R, Altorki N and Mittal V: Bone marrow-derived endothelial
progenitor cells contribute to the angiogenic switch in tumor
growth and metastatic progression. Biochim Biophys Acta.
1796:33–40. 2009.PubMed/NCBI
|
|
80
|
Erler JT, Bennewith KL, Cox TR, Lang G,
Bird D, Koong A, Le QT and Giaccia AJ: Hypoxia-induced lysyl
oxidase is a critical mediator of bone marrow cell recruitment to
form the premetastatic niche. Cancer Cell. 15:35–44. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hiratsuka S, Watanabe A, Aburatani H and
Maru Y: Tumour-mediated upregulation of chemoattractants and
recruitment of myeloid cells predetermines lung metastasis. Nat
Cell Biol. 8:1369–1375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Han C, Zhou J, Liu B, Liang C, Pan X,
Zhang Y, Zhang Y, Wang Y, Shao L, Zhu B, et al: Delivery of miR-675
by stem cell-derived exosomes encapsulated in silk fibroin hydrogel
prevents aging-induced vascular dysfunction in mouse hindlimb.
Mater Sci Eng C Mater Biol Appl. 99:322–332. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wiklander OP, Nordin JZ, O'Loughlin A,
Gustafsson Y, Corso G, Mäger I, Vader P, Lee Y, Sork H, Seow Y, et
al: Extracellular vesicle in vivo biodistribution is determined by
cell source, route of administration and targeting. J Extracell
Vesicles. 4:263162015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Peinado H, Lavotshkin S and Lyden D: The
secreted factors responsible for pre-metastatic niche formation:
Old sayings and new thoughts. Semin Cancer Biol. 21:139–146. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hameed A, Brady JJ, Dowling P, Clynes M
and O'Gorman P: Bone disease in multiple myeloma: Pathophysiology
and management. Cancer Growth Metastasis. 7:33–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Abdi J, Chen G and Chang H: Drug
resistance in multiple myeloma: Latest findings and new concepts on
molecular mechanisms. Oncotarget. 4:2186–2207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Rossi M, Pitari MR, Amodio N, Di Martino
MT, Conforti F, Leone E, Botta C, Paolino FM, Del Giudice T,
Iuliano E, et al: miR-29b negatively regulates human osteoclastic
cell differentiation and function: Implications for the treatment
of multiple myeloma-related bone disease. J Cell Physiol.
228:1506–1515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Heider U, Fleissner C, Zavrski I, Kaiser
M, Hecht M, Jakob C and Sezer O: Bone markers in multiple myeloma.
Eur J Cancer. 42:1544–1553. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Raimondi L, De Luca A, Amodio N, Manno M,
Raccosta S, Taverna S, Bellavia D, Naselli F, Fontana S, Schillaci
O, et al: Involvement of multiple myeloma cell-derived exosomes in
osteoclast differentiation. Oncotarget. 6:13772–13789. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Garimella R, Washington L, Isaacson J,
Vallejo J, Spence M, Tawfik O, Rowe P, Brotto M and Perez R:
Extracellular membrane vesicles derived from 143B osteosarcoma
cells contain pro-osteoclastogenic cargo: A novel communication
mechanism in osteosarcoma bone microenvironment. Transl Oncol.
7:331–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Raimondo S, Saieva L, Vicario E, Pucci M,
Toscani D, Manno M, Raccosta S, Giuliani N and Alessandro R:
Multiple myeloma-derived exosomes are enriched of amphiregulin
(AREG) and activate the epidermal growth factor pathway in the bone
microenvironment leading to osteoclastogenesis. J Hematol Oncol.
12:22019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Deng X, He G, Liu J, Luo F, Peng X, Tang
S, Gao Z, Lin Q, Keller JM, Yang T and Keller ET: Recent advances
in bone-targeted therapies of metastatic prostate cancer. Cancer
Treat Rev. 40:730–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Karlsson T, Lundholm M, Widmark A and
Persson E: Tumor cell-derived exosomes from the prostate cancer
cell line TRAMP-C1 impair osteoclast formation and differentiation.
PLoS One. 11:e01662842016. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Inder KL, Ruelcke JE, Petelin L, Moon H,
Choi E, Rae J, Blumenthal A, Hutmacher D, Saunders NA, Stow JL, et
al: Cavin-1/PTRF alters prostate cancer cell-derived extracellular
vesicle content and internalization to attenuate extracellular
vesicle-mediated osteoclastogenesis and osteoblast proliferation. J
Extracell Vesicles. 3:2014. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Shiozawa Y, Pedersen EA, Havens AM, Jung
Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, et al:
Human prostate cancer metastases target the hematopoietic stem cell
niche to establish footholds in mouse bone marrow. J Clin Invest.
121:1298–1312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Morrissey C, Lai JS, Brown LG, Wang YC,
Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E,
et al: The expression of osteoclastogenesis-associated factors and
osteoblast response to osteolytic prostate cancer cells. Prostate.
70:412–424. 2010.PubMed/NCBI
|
|
99
|
Itoh T, Ito Y, Ohtsuki Y, Ando M,
Tsukamasa Y, Yamada N, Naoe T and Akao Y: Microvesicles released
from hormone-refractory prostate cancer cells facilitate mouse
pre-osteoblast differentiation. J Mol Histol. 43:509–515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ye Y, Li SL, Ma YY, Diao YJ, Yang L, Su
MQ, Li Z, Ji Y, Wang J, Lei L, et al: Exosomal miR-141-3p regulates
osteoblast activity to promote the osteoblastic metastasis of
prostate cancer. Oncotarget. 8:94834–94849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Hashimoto K, Ochi H, Sunamura S, Kosaka N,
Mabuchi Y, Fukuda T, Yao K, Kanda H, Ae K, Okawa A, et al:
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in
the bone metastatic microenvironment via targeting ARHGAP1 and
FAM134A. Proc Natl Acad Sci USA. 115:2204–2209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Morhayim J, van de Peppel J, Demmers JA,
Kocer G, Nigg AL, van Driel M, Chiba H and van Leeuwen JP:
Proteomic signatures of extracellular vesicles secreted by
nonmineralizing and mineralizing human osteoblasts and stimulation
of tumor cell growth. FASEB J. 29:274–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Peng X, Guo W, Ren T, Lou Z, Lu X, Zhang
S, Lu Q and Sun Y: Differential expression of the RANKL/RANK/OPG
system is associated with bone metastasis in human non-small cell
lung cancer. PLoS One. 8:e583612013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Taverna S, Pucci M, Giallombardo M, Di
Bella MA, Santarpia M, Reclusa P, Gil-Bazo I, Rolfo C and
Alessandro R: Amphiregulin contained in NSCLC-exosomes induces
osteoclast differentiation through the activation of EGFR pathway.
Sci Rep. 7:31702017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Valencia K, Luis-Ravelo D, Bovy N, Antón
I, Martínez-Canarias S, Zandueta C, Ormazábal C, Struman I, Tabruyn
S, Rebmann V, et al: miRNA cargo within exosome like vesicle
transfer influences metastatic bone colonization. Mol Oncol.
8:689–703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kumar B, Garcia M, Weng L, Jung X,
Murakami JL, Hu X, McDonald T, Lin A, Kumar AR, DiGiusto DL, et al:
Acute myeloid leukemia transforms the bone marrow niche into a
leukemia-permissive microenvironment through exosome secretion.
Leukemia. 32:575–587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Guise TA: Breast cancer bone metastases:
It's all about the neighborhood. Cell. 154:957–959. 2013.
View Article : Google Scholar : PubMed/NCBI
|
